JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB92473

Anti-MSH2 antibody [EPR3943]

4

(4 Reviews)

|

(6 Publications)

Rabbit Recombinant Monoclonal MSH2 antibody. Suitable for WB and reacts with Human samples. Cited in 6 publications.

View Alternative Names

DNA mismatch repair protein Msh2, hMSH2, MutS protein homolog 2, MSH2

2 Images
Western blot - Anti-MSH2 antibody [EPR3943] (AB92473)
  • WB

Unknown

Western blot - Anti-MSH2 antibody [EPR3943] (AB92473)

Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : MSH2 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : A375 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab92473 observed at 115 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab92473 was shown to recognize MSH2 when MSH2 knockout samples were used, along with additional cross-reactive bands. Wild-type and MSH2 knockout samples were subjected to SDS-PAGE. ab92473 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-MSH2 antibody [EPR3943] (ab92473)

Predicted band size: 105 kDa

false

Western blot - Anti-MSH2 antibody [EPR3943] (AB92473)
  • WB

Unknown

Western blot - Anti-MSH2 antibody [EPR3943] (AB92473)

All lanes:

Western blot - Anti-MSH2 antibody [EPR3943] (ab92473) at 1/1000 dilution

Lane 1:

A375 cell lysate at 10 µg

Lane 2:

A431 cell lysate at 10 µg

Lane 3:

SW480 cell lysate at 10 µg

Lane 4:

HeLa cell lysate at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit antibody at 1/2000 dilution

Predicted band size: 105 kDa

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR3943

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "1/10 - 1/100", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

To see more of the key markers and tools you need to study the hallmarks of cancer, including genome instability and mutation, please visit the following page.

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MSH2 also known as MutS Homolog 2 is a human protein with a molecular weight of approximately 100 kDa. It is an important component of the DNA mismatch repair system and plays an essential role in maintaining genomic stability by recognizing and repairing mismatched nucleotides during DNA replication. Expression of the MSH2 protein occurs broadly in dividing cells across various tissues with notable presence in tissues with high proliferation rates such as the colon and the endometrium. Additionally detection and quantification of MSH2 are often performed using methodologies such as MSH2 ELISA which aids in the assessment of its expression levels in different biological samples.
Biological function summary

Components are identified in mismatch repair where MSH2 forms a heterodimer with MSH6 known as the MutSα complex or with MSH3 known as the MutSβ complex. This heterodimerization is critical for the initial steps in the recognition and binding of mismatch errors on the DNA strand. MSH2 complex formation enables it to scan the DNA for errors facilitating the recruitment of additional repair proteins. The activity of MSH2 in these complexes is important in preserving the fidelity of genetic information and prevents mutations that could lead to genomic instability.

Pathways

MSH2 operates within the DNA damage response and repair pathways. The protein is a core component of the mismatch repair pathway which corrects DNA replication errors that elude proofreading activity of DNA polymerases. It interacts with other proteins such as MLH1 and PMS2 forming a synergistic function that amplifies the capacity to recognize and initiate repair of mismatches. The pathway involving MSH2 not only repairs mismatched bases but also plays a role in cell cycle control checkpoints and apoptosis evidencing its pivotal role in maintaining cell cycle integrity.

Studies show that MSH2 is strongly associated with Lynch syndrome an autosomal dominant inherited condition that increases the risk of colorectal cancer. Mutations in the MSH2 gene impair its mismatch repair function and lead to microsatellite instability a hallmark of cancer cells in this disorder. Furthermore alterations in the MSH2 protein also relate to glioblastomas with correlations observed between MSH2 expression levels and tumor progression. These conditions exemplify the important role of MSH2 and its interaction with other DNA repair proteins in preventing cancerous developments.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Component of the post-replicative DNA mismatch repair system (MMR). Forms two different heterodimers : MutS alpha (MSH2-MSH6 heterodimer) and MutS beta (MSH2-MSH3 heterodimer) which binds to DNA mismatches thereby initiating DNA repair. When bound, heterodimers bend the DNA helix and shields approximately 20 base pairs. MutS alpha recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. MutS beta recognizes larger insertion-deletion loops up to 13 nucleotides long. After mismatch binding, MutS alpha or beta forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. Recruits DNA helicase MCM9 to chromatin which unwinds the mismatch containing DNA strand (PubMed : 26300262). ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch : mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. In melanocytes may modulate both UV-B-induced cell cycle regulation and apoptosis.
See full target information MSH2

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Cell reports. Medicine 5:101703 PubMed39216477

2024

A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib.

Applications

Unspecified application

Species

Unspecified reactive species

Arturo Simoni-Nieves,Moshit Lindzen,Suvendu Giri,Nitin Gupta,Rishita Chatterjee,Boobash-Raj Selvadurai,Marieke Van Daele,Danielle Love,Yuya Haga,Donatella Romaniello,Tomer-Meir Salame,Mirie Zerbib,Roni Oren,Yasuo Tsutsumi,Mattia Lauriola,Ilaria Marrocco,Yosef Yarden

PeerJ 9:e11481 PubMed34046266

2021

Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Na Yang,Yanhua Wu,Meishan Jin,Zhifang Jia,Yueqi Wang,Donghui Cao,Lili Qin,Xueying Wang,Min Zheng,Xueyuan Cao,Jing Jiang

Aging 13:9838-9858 PubMed33744866

2021

lncRNA SNHG4 modulates colorectal cancer cell cycle and cell proliferation through regulating miR-590-3p/CDK1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhongyi Zhou,Fengbo Tan,Qian Pei,Chenglong Li,Yuan Zhou,Yuqiang Li,Haiping Pei

Clinical epigenetics 11:153 PubMed31666131

2019

Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Hua Tian,Li Yan,Li Xiao-Fei,Sun Hai-Yan,Chen Juan,Kang Shan

International journal of clinical and experimental 8:1867-77 PubMed25973079

2015

Mismatch repair system in endometriotic tissue and eutopic endometrium of unaffected women.

Applications

Unspecified application

Species

Unspecified reactive species

Tiziana Grassi,Angelo Calcagno,Stefania Marzinotto,Ambrogio P Londero,Maria Orsaria,Gioia N Canciani,Carlo Alberto Beltrami,Diego Marchesoni,Laura Mariuzzi

Gynecologic oncology 131:309-14 PubMed23938375

2013

MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome.

Applications

ICC/IF

Species

Human

Gregg S Nelson,Aaron Pink,Sandra Lee,Guangming Han,Don Morris,Travis Ogilvie,Máire A Duggan,Martin Köbel
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com